acquired
Stage
2012
Founded
6
Investors
About
Axonics develops and commercializes implantable sacral neuromodulation systems for treating bladder and bowel dysfunction, including overactive bladder, fecal incontinence, and urinary retention.
Explore Axonics Modulation Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.